Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

for the Regain Study Group

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Fingerprint Dive into the research topics of 'Long-term safety and efficacy of eculizumab in generalized myasthenia gravis'. Together they form a unique fingerprint.

Medicine & Life Sciences